Health Care & Life Sciences » Pharmaceuticals | Henan Lingrui Pharmaceutical Co. Ltd.

Henan Lingrui Pharmaceutical Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
105,388.70
76,217.00
133,062.50
347,724.30
224,927.80
245,765.70
Depreciation, Depletion & Amortization
29,173.30
29,811.20
38,146.40
44,200.60
51,707.70
70,057
Other Funds
248,056.60
16,175.80
18,297.30
466,870.80
9,968.90
52,200.50
Funds from Operations
85,157.90
125,098.40
180,847.80
179,710.70
278,933.30
372,297
Changes in Working Capital
56,512.70
28,698.80
71,552.90
103,374.80
153,155.10
79,209.80
Net Operating Cash Flow
141,670.50
153,797.20
252,400.70
76,335.90
125,778.20
451,506.80
Capital Expenditures
166,877.80
102,104.00
97,386.30
218,049.30
257,553.80
Sale of Fixed Assets & Businesses
18,622.10
559.70
2,300.10
1,031.40
116,212.50
Purchase/Sale of Investments
62,832.40
146,291.50
30,889.10
28,886.10
17,160.70
Net Investing Cash Flow
138,857.20
247,835.80
64,197.10
264,687.10
124,180.60
Cash Dividends Paid - Total
22,905.80
53,559.70
32,120.80
88,848.10
88,848.10
Issuance/Reduction of Debt, Net
15,500.00
93,500.00
93,500.00
227,000.00
60,500.00
Net Financing Cash Flow
209,650.80
22,871.50
144,132.40
150,905.20
38,317.00
Net Change in Cash
212,474.50
71,194.30
44,306.10
37,119.60
36,926.20
Free Cash Flow
25,207.20
51,693.30
155,014.40
141,713.40
131,775.60
Deferred Taxes & Investment Tax Credit
8,480.20
3,782.60
11,015.00
9,763.50
27,125.20
4,273.80
Net Assets from Acquisitions
-
-
-
18,783.10
-
Other Sources
102,230.90
-
-
-
-
Change in Capital Stock
-
893.00
214.30
117.50
-
Exchange Rate Effect
10.40
27.40
234.90
326.40
206.80
Other Uses
30,000.00
-
-
-
-

About Henan Lingrui Pharmaceutical Co.

View Profile
Address
No. 666 Jiangjun Road
Xinyang Henan 465550
China
Employees -
Website http://www.lingrui.com
Updated 07/08/2019
Henan Lingrui Pharmaceutical Co., Ltd. engages in the production and operation of pharmaceutical products. It manufacture and sale ointments, tablets, capsules, and granule drugs. Its business activities include production and sales of medicines, health supplies, and medical equipment; and research and development, and provision of technical services of new products and new technologies.